Merus N.V

Market cap: $1,108,469,663

Exchange: NAS

Sector: Health Technology

Merus NV is a clinical-stage immune-oncology company, which engages in the discovery and development of bi-specific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. The company was founded by Ton Logtenberg on June 16, 2003 and is headquartered in Utrecht, Netherlands.

STOCK PRICE CHART

Key Statistics

Company Name

Merus N.V

Average Volume (10 days)

238,420

Average Volume (30 days)

316,167

Moving Average (50 days)

$28.24

Moving Average (200 days)

$23.27

Ex-Divided Date

n/a

Dividend Yield

0

P/E Ratio

0

Market Cap

1,108,469,663

Shares Outstanding

38,811,963

52-Week High Split Adjust Only

33

52-Week Low Split Adjust Only

15.5

Employee Count

117

Beta

0.508

Next Earnings Date

TTM Dividend Rate Per Share

0

Price Changes

Past 5 days

-0.02%

Past 30 days

0%

Past 3 months

0.29%

Past 6 months

0.34%

Past year

0.76%

Past 2 years

0.88%

Past 5 years

0.63%

Max % Change

1.84%

PEER GROUP COMPARATIVE PERFORMANCE

NameTickerPrice/Sales (ttm)Price/Book (ttm)Forward P/EPEG RatioEV/Revenue
Merus N.VMRUSn/an/a-9.9n/an/a
Peer AvgN/An/an/a-3.2n/an/a
ORIC Pharmaceuticals IncORICn/an/a-10.2n/an/a
Otonomy IncOTICn/an/a-2.6n/an/a